Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalised Risk Assessment in Febrile Illness to Optimise Real-life Management Across the European Union (PERFORM)

NCT05221437 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT05221437
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05221437 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalised Risk Assessment in Febrile Illness to Optimise Real-life Management Across the European Union (PERFORM)
Lead sponsor
Imperial College London
Phase
Observational
Overall status
Completed
Start date
January 1, 2017
Completion date
December 31, 2021
Enrollment
38,480 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

antibiotic prescription